Starpharma Umsatz
Was ist das Umsatz von Starpharma?
Umsatz von Starpharma Holdings Limited ist AUD$9.752M
Was ist die Definition von Umsatz?
Umsatz sind die Einnahmen, die ein Unternehmen aus seiner normalen Geschäftstätigkeit erzielt, normalerweise aus dem Verkauf von Waren und Dienstleistungen an Kunden.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Umsatz von Unternehmen in Health Care Sektor auf ASX im Vergleich zu Starpharma
Was macht Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Unternehmen mit umsatz ähnlich Starpharma
- Nuchev hat Umsatz von AUD$9.724M
- The Mandhana Retail Ventures hat Umsatz von ₨9.731M
- InvestSMART hat Umsatz von AUD$9.740M
- GLG Life Tech hat Umsatz von CAD$9.740M
- Inventiva SA hat Umsatz von €9.745M
- Inventiva S.A hat Umsatz von €9.745M
- Starpharma hat Umsatz von AUD$9.752M
- Entreprendre S.A hat Umsatz von €9.760M
- EQ hat Umsatz von CAD$9.760M
- Esports Entertainment hat Umsatz von $9.770M
- Ventus VCT Plc hat Umsatz von £9.797M
- Ventus VCT D hat Umsatz von $9.797M
- Ventus VCT C hat Umsatz von $9.797M